106 related articles for article (PubMed ID: 1572814)
41. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
Cheng JC; Peng LC; Chen YH; Huang DY; Wu JK; Jian JJ
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1010-8. PubMed ID: 14575832
[TBL] [Abstract][Full Text] [Related]
42. Treatment of recurrent pelvic and selected primary gynecologic malignancies with 241Am.
Chung JY; Roberts K; Peschel RE; Nath R; Pourang R; Kacinski B; Wilson L
Radiat Oncol Investig; 1997; 5(5):227-34. PubMed ID: 9372545
[TBL] [Abstract][Full Text] [Related]
43. Three-dimensional applicator system for carcinoma of the uterine cervix.
Weeks KJ; Montana GS
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):455-63. PubMed ID: 9069321
[TBL] [Abstract][Full Text] [Related]
44. Radiation dosimetry of a conformal heat-brachytherapy applicator.
Taschereau R; Stauffer PR; Hsu IC; Schlorff JL; Milligan AJ; Pouliot J
Technol Cancer Res Treat; 2004 Aug; 3(4):347-58. PubMed ID: 15270585
[TBL] [Abstract][Full Text] [Related]
45. Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume.
Dubray BM; Thames HD
Radiother Oncol; 1994 Oct; 33(1):41-7. PubMed ID: 7878208
[TBL] [Abstract][Full Text] [Related]
46. A dosimetric comparison between applicators used for brachytherapy in carcinoma cervix - A single-institute prospective study.
Suryadevara A; Kumar MV; Vasundhara E; Alluri KR; Ahamed S; Guduru S
Indian J Cancer; 2018; 55(3):230-232. PubMed ID: 30693884
[TBL] [Abstract][Full Text] [Related]
47. Development of a rat solid tumor model for continuous low-dose-rate irradiation studies using 125I and 103Pd sources.
Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
Brachytherapy; 2004; 3(3):159-72. PubMed ID: 15533809
[TBL] [Abstract][Full Text] [Related]
48. The dose rate dependence of the relative biological effectiveness of 241Am versus 226Ra gamma rays.
Schulz RJ; Bongiorni P
Radiat Res; 1989 Jun; 118(3):420-36. PubMed ID: 2727269
[TBL] [Abstract][Full Text] [Related]
49. [Manual afterloading applicators for intracavitary brachytherapy].
Tacev T; Krystof V; Dupák J; Kasták B; Rasovská O; Strnad V
Cesk Radiol; 1989 May; 43(3):194-7. PubMed ID: 2758507
[TBL] [Abstract][Full Text] [Related]
50. Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program.
Harkenrider MM; Surucu M; Harmon G; Mysz ML; Shea SM; Yacoub J; Goldberg A; Liotta M; Winder A; Potkul R; Roeske JC; Small W
Brachytherapy; 2018; 17(1):187-193. PubMed ID: 29089277
[TBL] [Abstract][Full Text] [Related]
51. Dosimetric optimization of a colpostat in a 60Co high-dose-rate brachytherapy unit for bladder sparing.
Zakariaee SS; Mahdavi SR
Brachytherapy; 2015; 14(1):37-45. PubMed ID: 25260688
[TBL] [Abstract][Full Text] [Related]
52. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
[TBL] [Abstract][Full Text] [Related]
53. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
54. Comparative analysis of rectal dose parameters in image-guided high-dose-rate brachytherapy for cervical cancer with and without a rectal retractor.
Gaudet M; Lim P; Yuen C; Zhang S; Spadinger I; Dubash R; Aquino-Parsons C
Brachytherapy; 2014; 13(3):257-62. PubMed ID: 24480263
[TBL] [Abstract][Full Text] [Related]
55. Changes in applicator positions and dose distribution between high dose rate brachytherapy fractions in cervix carcinoma patients receiving definitive radiotherapy.
Garipağaoğlu M; Tunçel N; Dalmaz MG; Gülkesen H; Toy A; Kizildağ AU; Köseoğlu FG
Br J Radiol; 2006 Jun; 79(942):504-9. PubMed ID: 16714753
[TBL] [Abstract][Full Text] [Related]
56. Shielding effects of Selectron applicator and pellets on isodose distributions.
Siwek RA; O'Brien PF; Leung PM
Radiother Oncol; 1991 Feb; 20(2):132-8. PubMed ID: 2031088
[TBL] [Abstract][Full Text] [Related]
57. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
58. Measurement of dose perturbation around shielded ovoids in high-dose-rate brachytherapy.
Hira M; Podgorsak MB; Jaggernauth W; Malhotra HK
Brachytherapy; 2011; 10(3):232-41. PubMed ID: 20932810
[TBL] [Abstract][Full Text] [Related]
59. High-dose-rate intracavitary brachytherapy: results of analyses of late rectal complications.
Sakata K; Nagakura H; Oouchi A; Someya M; Nakata K; Shido M; Koito K; Sagae S; Kudo R; Hareyama M
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1369-76. PubMed ID: 12459359
[TBL] [Abstract][Full Text] [Related]
60. [Chronic radiation sequelae in the rat rectum following intracavitary irradiation with different doses].
Kiszel Z; Spiethoff A; Trott KR
Strahlentherapie; 1985 Jun; 161(6):348-53. PubMed ID: 4012815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
